Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536. (Q39741527)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536. |
scientific article |
Statements
1 reference
Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536. (English)
1 reference
1 reference
Karoline V Gleixner
1 reference
Veronika Ferenc
1 reference
Alexander Gruze
1 reference
Renata A Meyer
1 reference
Matthias Mayerhofer
1 reference
Winfried F Pickl
1 reference
Christian Sillaber
1 reference
Peter Valent
1 reference
9 February 2010
1 reference
1 reference
Identifiers
1 reference